China News
-
Cipla launches first rheumatic drug biosimilar in India
China | News | By BioSpectrum Bureau | 0 Comment | 18 Apr, 2013
Mumbai: Cipla launched the first biosimilar of Etanercept in India under the brand name, Etacept, indicated for the trea...Read more
-
Dr Jianping Dai joins Cellular Biomedicine board
China | News | By BioSpectrum Bureau | 0 Comment | 15 Mar, 2013
Singapore: Cellular Biomedicine appointed Dr Jianping Dai to the board of directors. Dr Dai is a professor of radiology...Read more
-
Chinese govt grant for DelMar, Guangxi Wuzhou
China | News | By BioSpectrum Bureau | 0 Comment | 09 Jul, 2013
Singapore: DelMar Pharmaceuticals announced that the Chinese Bureau of Foreign Experts has approved the application for ...Read more
-
China summit to promote biomedical industry
China | News | By BioSpectrum Bureau | 0 Comment | 26 Dec, 2012
Singapore: BioMed Innovation Summit 2013 will launch on March 14-15, 2013, in Shanghai, China, in order to promote the ...Read more
-
James Thorburn to lead UK CRO TranScrip in Hong Kong
China | News | By BioSpectrum Bureau | 0 Comment | 03 Oct, 2013
Singapore: TranScrip Partners, a UK-based specialist contract research organization (CRO) that started its operation in ...Read more
-
Low R&D output, patent cliffs drives big pharma nuts
China | Analysis | By BioSpectrum Bureau | 1 Comment | 05 Sep, 2012
Singapore: According to the latest global report from industry experts, GBI Research, low R&D productivity, combined...Read more
-
China | News | By BioSpectrum Bureau | 0 Comment | 08 Feb, 2013
Singapore: China Cord Blood (CCB), which is the first and largest cord blood banking operator in China, highlighted that...Read more
-
GSK's Mark Reilly to return to China shortly
China | News | By BioSpectrum Bureau | 0 Comment | 29 Jul, 2013
Singapore: GlaxoSmithKline's former China head Mr Mark Reilly would be returning to China shortly to assist the police w...Read more
-
3SBio retains Gottlieb Steen & Hamilton as legal counsel
China | News | By BioSpectrum Bureau | 0 Comment | 18 Sep, 2012
Singapore: 3SBio, a leading China-based biotechnology company focused on R&D, manufacturing and marketing biopharma...Read more
-
Mr Steven Kaufman, SHL Group: 2013 will be an exciting year for drug delivery devices
China | Opinion | By BioSpectrum Bureau | 0 Comment | 25 Dec, 2012
Pharmaceutical companies in the region are starting to take more interest in biologics and biosimilars, and of course wi...Read more
-
China Cord Blood revenues up 57% to $24.0 mn
China | Company results | By BioSpectrum Bureau | 5 Comment | 27 Feb, 2013
Singapore: China Cord Blood, China's leading provider of cord blood collection, laboratory testing, hematopoietic stem c...Read more
-
Sanjiu Medical keeps focus on R&D
China | Analysis | By BioSpectrum Bureau | 0 Comment | 21 Jun, 2012
Sanjiu Medical and Pharmaceutical is a manufacturing and marketing company for medicines, healthcare products, and medic...Read more
-
GSK executives confessed to bribery charges: China
China | News | By BioSpectrum Bureau | 0 Comment | 12 Jul, 2013
Singapore: Two weeks after intense investigations into GlaxoSmithKline's (GSK) operations across China, the country's se...Read more
-
J&J puts all Chinese units under single local chairman
China | News | By BioSpectrum Bureau | 0 Comment | 29 Aug, 2013
Singapore: The business heads of Johnson & Johnson's (J&J) three Chinese operations would report to one local ch...Read more
-
China develops revolutionary TCM migraine medication
China | News | By BioSpectrum Bureau | 0 Comment | 18 Jul, 2012
Singapore: China Health Resource (CHRI) has developed a revolutionary TCM migraine medication called Toufeng Migraine ta...Read more
-
Can-Fite APIs to be manufactured by China CRO
China | News | By BioSpectrum Bureau | 0 Comment | 24 Jan, 2013
Singapore: Israel-based Can-Fite BioPharma announced that the active pharmaceuticals ingredients (API) of CF101 and CF1...Read more
-
X-Change to launch Phytiva in China, SE Asia
China | News | By BioSpectrum Bureau | 0 Comment | 28 Jan, 2013
Singapore: X-Change, a US-based boutique company whose niche is extract-based cosmeceutical and nutraceutical solutions ...Read more
-
OrbusNeich launches dual therapy heart stent
China | News | By BioSpectrum Bureau | 0 Comment | 29 May, 2013
Singapore: Hong Kong-based OrbusNeich has launched dual therapy stent to address the challenges of delayed healing of th...Read more
